Showing 81 - 100 results of 146 for search '"Substance use disorder"', query time: 0.06s Refine Results
  1. 81

    Inverse association between obesity and suicidal death risk by Joonyub Lee, Seung-Hwan Lee, Mee-Kyoung Kim, Hyuk-Sang Kwon, Jae-Seung Yun, Yeoree Yang, Kun-Ho Yoon, Jae-Hyoung Cho, Chi-Un Pae, Kyungdo Han, Jang Won Son

    Published 2025-01-01
    “…Multivariate Cox proportional hazard regression analysis was performed to estimate the risk of suicidal death with respect to BMI categories after adjusting for potential confounders (age, sex, income, diabetes, hypertension, dyslipidemia, smoking, drinking, exercise, self-abuse, waist circumference, schizophrenia, bipolar disorder, eating disorder, cancer, anxiety, and substance use disorder). Results Underweight individuals had an increased risk (hazard ratio [HR] 1.44, 95% confidence interval [CI] 1.31–1.57) while overweight (HR 0.79, 95% CI 0.76–0.83), class I (HR 0.76, 95% CI 0.71–0.80) and class II obesity (HR 0.71, 95% CI 0.63–0.81) were associated with decreased risks of suicidal deaths compared to those of the normal weight individuals (BMI 18.5–23). …”
    Get full text
    Article
  2. 82
  3. 83

    Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study by Rolando Barrios, Julio S G Montaner, Silvia Guillemi, Ni Gusti Ayu Nanditha, Viviane D Lima, Thomas L Patterson, Fidel Vila-Rodriguez, William G Honer, Jason Trigg, Hasan Nathani, Sara Shayegi-Nik, Weijia Yin, Alejandra Fonseca, Bronhilda T Takeh

    Published 2024-04-01
    “…Among the adjusted covariates, CD4 cell count<50 cells/mm3 (adjusted CSH (aCSH) 8.61, 95% CI: 4.75 to 15.60), uncontrolled viremia (aCSH 1.95, 95% CI: 1.20 to 3.17), 10-year increase in age (aCSH 2.41, 95% CI: 1.89 to 3.07), schizophrenia (aCSH 2.85, 95% CI: 1.69 to 4.80), traumatic brain injury (aCSH 2.43, 95% CI: 1.59 to 3.71), delirium (aCSH 2.27, 95% CI: 1.45 to 3.55), substance use disorder (SUD) (aCSH 1.94, 95% CI: 1.18 to 3.21) and mood/anxiety disorders (aCSH 1.80, 95% CI: 1.13 to 2.86) were associated with an increased hazard for dementia. …”
    Get full text
    Article
  4. 84

    Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care. by Tea Rosic, Glenda Babe, Myanca Rodrigues, Brittany B Dennis, Richard Perez, Claire de Oliveira, Andrew Worster, Lehana Thabane, Zainab Samaan

    Published 2025-01-01
    “…Studying integrated mental health and substance use disorder treatment in the outpatient setting should be a priority to bolster care for this population.…”
    Get full text
    Article
  5. 85

    Associations between Pathological Gambling and Psychiatric Comorbidity among Help-Seeking Populations in Hong Kong by Daniel T. L. Shek, Elda M. L. Chan, Ryan H. Y. Wong

    Published 2012-01-01
    “…Participants (N=201) who sought gambling counseling were examined by making Axis-I diagnoses including mood disorders, schizophrenia spectrum disorders, substance use disorders, anxiety disorders, and adjustment disorder. …”
    Get full text
    Article
  6. 86

    Emotional Experiences of Mental Health First Aid Trainees: A Qualitative Study by Alexander E. Chan, Emma T. Kniola, Raya Francis

    Published 2024-07-01
    “…Mental Health First Aid (MHFA) is a program that helps participants identify, understand, and respond to mental health and substance use disorders. Research studies focusing on the emotional experiences of MHFA participants are lacking. …”
    Get full text
    Article
  7. 87

    Substance Abuse: A Public Health Concern by Ulfat Amin, Adil Mudasir Malla, Ishrat Amin, Roohi Jan

    Published 2023-12-01
    “…Alcohol, nicotine, and other illicit drugs are frequently used in excess in substance use disorders, which can impair social, academic, and professional functioning. …”
    Get full text
    Article
  8. 88

    Mental Health Insurance in India: An Examination of Policy Implementation Post-MHCA 2017 by Vijaya Chandra Reddy Avula, Sangha Mitra Godi, Shashidhara Munivenkatappa, Sridhar Amalakanti

    Published 2025-01-01
    “…The majority of the companies did not cover suicide and substance use disorders. There are disparities in the outpatient care offerings, including extended waiting periods for coverage of mental illness.  …”
    Get full text
    Article
  9. 89

    Alcohol consumption associated with suicidal ideation, and suicide attempts in substance users: A cross-sectional study of an addiction registry in western Iran. by Vahid Farnia, Mahsa Mohebian, Omran Davarinejad, Denise A Hien, Safora Salemi, Sara Hookari, Hafez Bajoghli, Bahareh Rahami

    Published 2025-01-01
    “…<h4>Background</h4>Suicide is recognized as a major problem worldwide and is particularly prevalent among specific groups, including individuals with substance use disorders (SUDs). The present study aimed to investigate alcohol consumption as a risk factor for suicidal ideation and attempts among those with substance use disorders (SUDs) in western Iran.…”
    Get full text
    Article
  10. 90
  11. 91

    Place of death and healthcare utilisation at the end of life among individuals with mental and behavioural disorders as underlying cause of death: population-level multiple-registe... by Maja Magdalena Olsson, Christopher Holmberg, Cecilia Larsdotter, Stina Nyblom, Joakim Öhlén

    Published 2025-01-01
    “…Those with MBDs, particularly substance use disorders, face a high risk of premature death, highlighting gaps in healthcare and palliative care provision for these populations. …”
    Get full text
    Article
  12. 92

    Association Between GABRG2 and Self-Rating of the Effects of Alcohol in a French Young Adult Sample by Moe JS, Bramness JG, Bolstad I, Mørland JG, Gorwood P, Ramoz N

    Published 2025-01-01
    “…Jenny Skumsnes Moe,1,2 Jørgen G Bramness,1– 4 Ingeborg Bolstad,1,5 Jørg Gustav Mørland,3,6 Philip Gorwood,7,8 Nicolas Ramoz7,8 1Research Center for Substance Use Disorders and Mental Illness, Innlandet Hospital Trust, Brumunddal, Norway; 2Institute for Clinical Medicine, The Arctic University of Norway, Tromsø, Norway; 3Department of Alcohol, Tobacco, and Drugs, Norwegian Institute of Public Health, Oslo, Norway; 4Section for Clinical Addiction Research, Oslo University Hospital, Oslo, Norway; 5Department of Health and Social Science, Inland Norway University of Applied Sciences, Elverum, Norway; 6Institute of Clinical Medicine, University of Oslo, Oslo, Norway; 7Université Paris Cité, Inserm U1266, Institut de Psychiatrie et Neurosciences de Paris (IPNP), Team Vulnerability of Psychiatric and Addictive Disorders, Paris, France; 8GHU PARIS Psychiatrie & Neurosciences, Hôpital Sainte-Anne, CMME, Paris, FranceCorrespondence: Jenny Skumsnes Moe, Research Center for Substance Use Disorders and Mental Illness, Innlandet Hospital Trust, P.O. …”
    Get full text
    Article
  13. 93

    Retrotransposons and the brain: Exploring a complex relationship between mobile elements, stress, and neurological health by Amelia Cuarenta

    Published 2025-01-01
    “…Early life stress (ELS) is linked to an increased risk for various psychiatric disorders including anxiety, depression, and substance use disorders. Epigenetic mechanisms have increasingly been of interest to understand how environmental factors contribute to reprogramming the brain and alter risk and resilience to developing psychiatric disorders. …”
    Get full text
    Article
  14. 94

    A Review of Nonanesthetic Uses of Ketamine by Abby Pribish, Nicole Wood, Arun Kalava

    Published 2020-01-01
    “…MEDLINE, CINAHL, and Google Scholar databases were queried to find articles related to ketamine in the treatment of depression, pain syndromes including acute pain, chronic pain, and headache, neurologic applications including neuroprotection and seizures, and alcohol and substance use disorders. It can be concluded that ketamine has a potential role in the treatment of all of these conditions. …”
    Get full text
    Article
  15. 95

    Correlation between Traits of Emotion-Based Impulsivity and Intrinsic Default-Mode Network Activity by Jizheng Zhao, Dardo Tomasi, Corinde E. Wiers, Ehsan Shokri-Kojori, Şükrü B. Demiral, Yi Zhang, Nora D. Volkow, Gene-Jack Wang

    Published 2017-01-01
    “…Negative urgency (NU) and positive urgency (PU) are implicated in several high-risk behaviors, such as eating disorders, substance use disorders, and nonsuicidal self-injury behavior. …”
    Get full text
    Article
  16. 96

    Distress is not delicious: Appetitive conditioning is weaker with high psychological distress by Laurens T. Kemp, Tom Smeets, Anita Jansen, Katrijn Houben

    Published 2025-01-01
    “…Appetitive and aversive conditioning seemingly plays a role in the development and maintenance of various psychopathologies, including anxiety, mood, eating, and substance use disorders. However, studies on conditioning typically only study either appetitive or aversive conditioning in the context of psychopathology, and they are poorly integrated. …”
    Get full text
    Article
  17. 97

    Comprehensive synthesis of mHealth interventions in psychiatry: insights from systematic, scoping, narrative reviews and content analysis by Zaakira Shahul Hameed Mahreen, Noor Azziah Zainuldin, Melvyn Weibin Zhang

    Published 2024-10-01
    “…Additionally, mHealth shows promise in managing substance use disorders and severe mental illnesses like schizophrenia, bipolar disorder and psychosis. …”
    Get full text
    Article
  18. 98

    Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA by Corey McBrayer DO, FAAP, Fangqian Ouyang MS, Zachary Adams PhD, Leslie Hulvershorn MD, Matthew C. Aalsma PhD

    Published 2022-08-01
    “…Methods Youth Medicaid claims from 2007-2017 processed in a large Midwestern city were analyzed for a diagnosis of TUD, related pharmacotherapy, and externalizing mental health and substance use disorders. Results Claims connected 6541 patients with 42 890 visits. …”
    Get full text
    Article
  19. 99

    Use of the Mental Health Gap Action Programme (mhGAP) by mental health volunteers in the UK: examples from South Asian diaspora charities by Leya Luhar, Aditi Arya, Raeesah Rafiq, Nandini Chakraborty

    “…The Mental Health Gap Action Programme (mhGAP) was launched by the World Health Organization (WHO) in 2008 to scale up services for mental, neurological and substance use disorders for low- and lower-middle-income countries. …”
    Get full text
    Article
  20. 100

    Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel by Miquel Bernardo, Marina Díaz Marsá, Ana González-Pinto, Manuel Martín Carrasco, Víctor Pérez Sola, Pilar Alejandra Sáiz, Eduard Vieta, Marta Torrens, Celso Arango, Benedicto Crespo-Facorro

    Published 2025-01-01
    “…Expert Opinion In our experience, lurasidone has shown efficacy in FEP in different patient profiles, including those with psychoses associated with substance use disorders. Lurasidone provides clinically relevant benefits, especially in patients with affective symptomatology, and has a good tolerability profile.…”
    Get full text
    Article